Addictions Therapeutics Market Size & Research Report to 2027

report image

Addictions Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Treatment Type (Opioid Addiction Treatment, Alcohol Addiction treatment, Nicotine Addiction treatment, Other substance addiction treatment); Drug Type (Nalaxone, Naltrexone, Bupropion, Disulfiram, Nicotine replacement products, Methadone, Varenicline); Treatment Center (Inpatient treatment center, Residential treatment Center, Outpatient Treatment Center); Distribution Channel (Hospital Pharmacies, Medical stores, Others) and Geography

Publication Month: Nov 2020 | Report Code: TIPRE00015265 | No. of Pages: 195 | Category: Pharmaceuticals | Status: Published

The addictions therapeutics market was valued at US$ 6,691.01 million in 2019 and is projected to reach US$ 10,735.94 million by 2027; it is expected to grow at a CAGR of 6.2% from 2020 to 2027.

Addiction is a psychological and physical inability to stop consuming drugs, alcohol, opioids, and related category substances, even though the consumption of those substances causes various mental and physical harms. Addiction can be life-threatening if not stopped. Therefore, there are several options such as drug therapy and rehabilitation to stop addiction in a better way. Rising addictions among common people and increasing awareness campaigns drive the growth of the addictions therapeutics market. Moreover, the rising demand for R&D from contract organizations is expected to bolster the market growth during the forecast period. However, steep costs of drug development restrict the market growth.

In North America, the US is the most affected country due to the pandemic of the COVID-19 outbreak. The country has reported the highest number of COVID-19 positive cases. Across the nation, various healthcare research centers are working on the COVID-19 therapeutics. The demand for addictions therapeutics are reduced due to lockdown and supply chain disruptions across the region, which hinders the growth of the addictions therapeutics market.


Lucrative Regions for Addictions Therapeutics Market



Lucrative Regions for Addictions Therapeutics Market

Get more information on this report :


Market Insights

Rising Addiction among General Populace Drives Addictions Therapeutics Market Growth

Drug addiction, also referred to as substance disorder, leads to harmful consequences and hampers an individual’s brain, behavior, and metabolic processes leading to an inability of control. Also, prescription drug abuse is becoming a serious issue worldwide. The addiction of abusive substances is responsible for the death of millions of people across the world. According to the National Institute on Drug Abuse (NIDA), ~21 million people had at least one addiction worldwide in 2019, out of which only 10% received treatment for the same.

Alcohol and drug addiction cause a high economic burden to various countries across the world. According to the Addiction Center, US, drug and alcohol addiction costs the US economy ~US$ 600 billion every year. According to the Global Change Data Lab, ~350,000 people across the world die each year due to drug overdose. The data also suggests that ~1.5% of the global disease burden results as an outcome of excessive alcohol consumption and illicit drug addiction. This percentage in a few countries is up to 5%.

According to a national study conducted by the AlIMS-Delhi in association with 10 medical institutes and 15 NGOs in 2019, a substantial percentage of Indians used psychoactive substances such as drugs, cannabis, and alcohol. According to the Addiction Center, ~11% of the French population used cannabis at some point between 2017 and 2017. Moreover, in 2017, ~41,000 deaths were reported in France due to the consumption of alcohol. Amphetamines and cocaine are popularly used among the German population. However, the reports of Addiction Center state that the number of people undertaking treatments for addictions has increased in recent years. The rising awareness about addiction treatments is another factor that is likely to support the growth of the addition therapeutics market in the coming years.

Treatment Type-Based Insights

Based on treatment type, the addictions therapeutics market is segmented into nicotine addiction treatment, alcohol addiction treatment, opioid addiction treatment, and other substance addiction treatment. The nicotine addiction treatment segment held the largest share of the market in 2019, and it is anticipated to register the highest CAGR during the forecast period. The growth of the market for nicotine addiction treatment segment is attributed to rising anti-smoking policies and growing awareness regarding the side effects of nicotine consumption.

Addictions Therapeutics Market, by Treatment Type – 2019 and 2027



Addictions Therapeutics Market, by Treatment Type – 2019 and 2027

Get more information on this report :


Drug Type -Based Insights

Based on drug type, the addictions therapeutics market is segmented into varenicline, bupropion, nicotine replacement products, buprenorphine, naltrexone, disulfiram, and others. The varenicline segment held the largest market share in 2019. The nicotine replacement products segment is anticipated to register the highest CAGR during the forecast period. The market growth for the nicotine replacement products segment can be attributed to the rising number of smokers and increasing launches of nicotine replacement products. For instance, GlaxoSmithKline offers a wide range of NRT products such as Nicotinell Chewing Gum, Nicotinell Compressed Lozenge, and Nicotinell 24 Hour Patch.

Treatment Center -Based Insights

Based on treatment center, the addictions therapeutics market is segmented into outpatient treatment center, residential treatment center, and inpatient treatment center. In 2019, the outpatient treatment center segment held the largest share of the market. The growth of the market for this segment is attributed to the high preference for outpatient treatment centers as these centers offer less expensive treatments with a flexible time schedule.

Strategic Insights

Report Coverage - Addictions Therapeutics Market
Report CoverageDetails
Market Size Value inUS$ 6,691.01 Million in 2019
Market Size Value byUS$ 10,735.94 Million by 2027
Growth rateCAGR of 6.2% from 2020-2027
Forecast Period2020-2027
Base Year2020
No. of Pages195
No. of Tables111
No. of Charts & Figures80
Historical data availableYes
Segments coveredTreatment Type ; Drug Type ; Treatment Center ; Distribution Channel and Geography
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Various companies operating in the addictions therapeutics market adopt strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain brand name, and meet growing demand from end users.


Addictions Therapeutics Market – by Treatment Type

  • Opioid Addiction Treatment
  • Alcohol Addiction Treatment
  • Nicotine Addiction Treatment
  • Other Substance Addiction Treatment


Addictions Therapeutics Market – by Drug Type

  • Buprenorphine
  • Naltrexone
  • Bupropion
  • Disulfiram
  • Nicotine Replacement Products
  • Varenicline
  • Others


Addictions Therapeutics Market – by Treatment Center

  • Inpatient Treatment Center
  • Residential Treatment Center
  • Outpatient Treatment Center


Addictions Therapeutics Market – by Distribution Channel

  • Hospital Pharmacies
  • Medical Stores
  • Others


Addictions Therapeutics Market– by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Indivior PLC
  • Pfizer, Inc.
  • GlaxoSmithKline Plc
  • Bausch Health Companies
  • Cipla, Inc.
  • Orexo AB
  • Purdue Pharma L.P.
  • Alvogen
  • Camurus AB
  • Hikma Pharmaceuticals Plc

Frequently Asked Questions

Addiction is a psychological and physical inability to stop consuming drugs, alcohol, Opioids, and related category substances, even though those substances have various mental and physical harms. An addiction develops dependency in a person to take that substance. Addiction can be life-threatening if not stopped. So, to stop addictions, there are several options available such as drug therapy, rehabilitation; which can stop addiction in a better way.
Rising addiction among general populace and conduction of awareness campaigns are driving the growth of the market. Moreover, rising demand for R&D from contract organizations is also expected to foster market growth.
Steeping costs of drug development is expected to hamper the growth of the market. The drug industry plays a significant role in the development of medicines and management of life-threatening diseases. The process of drug discovery includes the identification of candidates, synthesis, characterization, screening & assays for therapeutic efficacy. Developing a new drug is a multibillion-dollar investment for the manufacturers.

The List of Companies - Addictions Therapeutics Market

  1. Cipla Ltd
  2. Indivior Plc
  3. Pfizer Inc
  4. Orexo Ab,
  5. Glaxosmithkline Plc
  6. Purdue Pharma L.P
  7. Alvogen
  8. Bausch Health
  9. Camurus Ab
  10. Hikma Pharmaceuticals Plc
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the addictions therapeutics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global addictions therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00015265
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




christmas_festive_offer

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000 $2700
  • $4550 $3640
  • $6550 $5240
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount